Sales & Marketing
HCPs, DOLs
Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Articles
Breaking down pharma silos to build value

Breaking down pharma silos to build value

As the pharma industry wrestles with new ways of working that can deliver valuable medicines to market, Nick Proctor explores how it can break down internal silos and ensure more nimble and eff

Articles
Five lessons from GSK in social media

Five lessons from GSK in social media

In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space.

Articles
Your health, yourself: Conclusion

Your health, yourself: Conclusion

In the concluding part of this series by Ogilvy CommonHealth Worldwide on the quantified-self movement, we review what we have learnt by meeting our five patients with their separate health con

Sales & Marketing

Sales & Marketing
HCPs, DOLs
Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Digital

Market Access

Editor's Picks

  1. Novartis halts CAR-T trials after patient deaths
  2. White House signs pricing deals with nine more pharmas
  3. Enhertu OK ends 10-year EU gap in frontline breast cancer
  4. Roche taps Simcere for autoimmune trispecific for $1.53bn
  5. Hutchmed rises on $1.3bn KRAS licensing deal with GSK

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

more

Patients

more

R&D

more